Ascorbic acid IV (ASCOR)
ASCOR has a defined scurvy indication, not a general high-dose wellness indication.
FDA-approved product context
ASCOR has a defined scurvy indication, not a general high-dose wellness indication.
Reviewed October 10, 2026. Product and route distinctions stay attached to the source; this is not a treatment recommendation.
Evidence and source limits
The retrieved ASCOR label identifies intravenous ascorbic acid for short-term scurvy treatment in adults and pediatric patients age five months and older when oral administration is not possible, insufficient or contraindicated. It is not indicated for vitamin C deficiency without scurvy signs and symptoms.
Product-specific warnings, including renal and glucose-6-phosphate dehydrogenase considerations, require professional review. No dose, dilution or infusion instructions are supplied.
Approval applies to the specific labeled product, route and indication, not every preparation of this ingredient or a wellness mixture. Read the original full label and discuss individual circumstances with a medical professional. No dosing or preparation instructions are included.
Original source: Ascorbic acid IV (ASCOR) ↗
Interpretation is limited to the source linked above. Educational source review, not independent medical review. No dosing, preparation instructions, seller links or treatment endorsement.